FBK Q1 2026 Earnings EPS Slightly Below Estimates amid Mixed Market Conditions USPH Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Despite Operational Consistency ESRT Q1 2026 Earnings Positive EPS Amid Quiet Quarter Conduent Q1 2026 Earnings EPS Surprises Significantly Above Estimates Stock Surges Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage ALBT Q1 2026 Earnings Narrowing Losses and Strategic Progress Amid No Revenue